A Phase I Trial of Fostamatinib before Chronic Graft-vs.-Host Disease Development after Allogeneic Stem Cell Transplantation
Clinical Trial Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Rigel Inc
Start Date
August 5, 2015
End Date
August 4, 2018
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Rigel Inc
Start Date
August 5, 2015
End Date
August 4, 2018